Atlas Trials

Randomized Phase II Trial on Safety and Neutralizing Activity of CL184 and Rabies Vaccine Versus Human Rabies Immune Globulin (HRIG) and Rabies Vaccine in Children and Adolescents

Clinical trial NCT00708084 · COMPLETED

Trial details

NCT number
NCT00708084
Sponsor
Crucell Holland BV
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Rabies
Start date
2008-05-01
Primary completion
2008-10-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.